NOVYRA PHARMACHEM — 360° view

NOVYRA PHARMACHEM, a company in the Tea & Coffee industry, reported revenue of ₹4.23 crore and a net loss of ₹0.03 crore for the September 2026 quarter.

NOVYRA PHARMACHEM (BSE: NOVYRA) closed at ₹8.88 on 20 Nov 2026, down 15.3% over the past year. Its market capitalisation is ₹6 crore.

Share price
₹8.88 (20 Nov 2026)
Market cap
₹6 Cr (20 Nov 2026)
Revenue
₹4 Cr (September 2026 quarter)
Net profit
₹-0 Cr (September 2026 quarter)
ROCE
-162% (FY26)
ROE
-162% (FY26)
Book value
₹0.90 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹16.55 / ₹7.35 (20 Nov 2026)
1-year return
-15.3% (to 20 Nov 2026)
Sector
Fast Moving Consumer Goods
Industry
Tea & Coffee
Symbol
BSE: NOVYRA

Incorporated in 1987, Bansisons Tea Industries Ltd produces tea, and leases tea garden

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.